<DOC>
	<DOCNO>NCT01587664</DOCNO>
	<brief_summary>The objective clinical study evaluate safety efficacy NewBreez intra-laryngeal implant patient dysfunctional larynx .</brief_summary>
	<brief_title>NewBreez Safety Efficacy Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Deglutition Disorders</mesh_term>
	<criteria>1 . Age &gt; 18 year old 2 . Congenital acquire , central peripheral , neurological neuromuscular disorder associate laryngeal dysfunction aspiration 3 . Has tracheotomy tracheostomy indicate use hood wean kit 4 . Must able comply study requirement duration study outline protocol . This include comply visit schedule well study specific procedure : scanner , radiographic swallowing study , nasopharyngoscopy , NewBreez ILP implant well qualityoflife evaluation 5 . Must able understand willing provide write informed consent 1 . Any condition precludes insertion NewBreez ILP ancillary implantation device 2 . Major swallow disorder 3 . Existing coagulation disorder 4 . Previous esophageal stenting 5 . Lifeexpectancy &lt; 12 month 6 . Be pregnant breastfeed intention become pregnant study ( female childbearing potential ) Point enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Swallowing disorder</keyword>
	<keyword>Aspiration</keyword>
</DOC>